Siemens Healthineers, Biogen Announce Agreement to Jointly Develop New MRI Tools for Multiple Sclerosis
January 17, 2017
January 17, 2017
MALVERN, Pa., Jan. 17 -- Siemens Healthineers (formerly the Siemens Healthcare) issued the following news release:
Siemens Healthineers and Biogen have announced that the companies plan to jointly develop magnetic resonance imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Biogen is a leading biotechnology company with a deep focus on neurological and autoimmune conditions, which for two decades has b . . .
Siemens Healthineers and Biogen have announced that the companies plan to jointly develop magnetic resonance imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Biogen is a leading biotechnology company with a deep focus on neurological and autoimmune conditions, which for two decades has b . . .